ES2559758T3 - Biomarcadores de cáncer de pulmón y usos de los mismos - Google Patents

Biomarcadores de cáncer de pulmón y usos de los mismos Download PDF

Info

Publication number
ES2559758T3
ES2559758T3 ES09813557.7T ES09813557T ES2559758T3 ES 2559758 T3 ES2559758 T3 ES 2559758T3 ES 09813557 T ES09813557 T ES 09813557T ES 2559758 T3 ES2559758 T3 ES 2559758T3
Authority
ES
Spain
Prior art keywords
erbb1
scfsr
cadherinae
rgm
ptn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09813557.7T
Other languages
English (en)
Spanish (es)
Inventor
Larry Gold
Marty Stanton
Edward N. Brody
Rachel M. Ostroff
Dominic Zichi
Alex A. E. Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Somalogic Inc
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Application granted granted Critical
Publication of ES2559758T3 publication Critical patent/ES2559758T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10—Complex mathematical operations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mathematical Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Theoretical Computer Science (AREA)
  • Algebra (AREA)
  • Software Systems (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Databases & Information Systems (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Pure & Applied Mathematics (AREA)
  • Mathematical Optimization (AREA)
  • Mathematical Analysis (AREA)
ES09813557.7T 2008-09-09 2009-09-09 Biomarcadores de cáncer de pulmón y usos de los mismos Active ES2559758T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9559308P 2008-09-09 2008-09-09
US95593P 2008-09-09
US15283709P 2009-02-16 2009-02-16
US152837P 2009-02-16
PCT/US2009/056399 WO2010030697A1 (en) 2008-09-09 2009-09-09 Lung cancer biomarkers and uses thereof

Publications (1)

Publication Number Publication Date
ES2559758T3 true ES2559758T3 (es) 2016-02-15

Family

ID=42005456

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09813557.7T Active ES2559758T3 (es) 2008-09-09 2009-09-09 Biomarcadores de cáncer de pulmón y usos de los mismos

Country Status (14)

Country Link
EP (1) EP2340506B1 (cg-RX-API-DMAC7.html)
JP (1) JP5701212B2 (cg-RX-API-DMAC7.html)
KR (1) KR101658347B1 (cg-RX-API-DMAC7.html)
CN (2) CN102209968B (cg-RX-API-DMAC7.html)
AU (2) AU2009291811B2 (cg-RX-API-DMAC7.html)
CA (3) CA3152591C (cg-RX-API-DMAC7.html)
DK (1) DK2340506T3 (cg-RX-API-DMAC7.html)
ES (1) ES2559758T3 (cg-RX-API-DMAC7.html)
GB (1) GB2478441B (cg-RX-API-DMAC7.html)
HK (1) HK1204062A1 (cg-RX-API-DMAC7.html)
HR (1) HRP20160127T1 (cg-RX-API-DMAC7.html)
MX (1) MX2011002322A (cg-RX-API-DMAC7.html)
SI (1) SI2340506T1 (cg-RX-API-DMAC7.html)
WO (1) WO2010030697A1 (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10359425B2 (en) 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
JP2012520469A (ja) 2009-03-12 2012-09-06 キャンサー・プリヴェンション・アンド・キュア，リミテッド 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
US20130116150A1 (en) 2010-07-09 2013-05-09 Somalogic, Inc. Lung Cancer Biomarkers and Uses Thereof
KR101857462B1 (ko) 2010-08-13 2018-05-14 소마로직, 인크. 췌장암 바이오마커 및 그것의 용도
CA2832480C (en) * 2011-04-07 2022-05-31 The Scripps Research Institute High-throughput screening for compounds modulating expression of cellular macromolecules
EP2702411A4 (en) * 2011-04-29 2015-07-22 Cancer Prevention & Cure Ltd METHOD FOR IDENTIFICATION AND DIAGNOSIS OF LUNG DISEASES USING CLASSIFICATION SYSTEMS AND KITS THEREFOR
EP2771692B1 (en) * 2011-10-24 2018-04-18 Somalogic, Inc. Lung cancer biomarkers and uses thereof
US9304137B2 (en) 2011-12-21 2016-04-05 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
US11913957B2 (en) 2011-12-21 2024-02-27 Biodesix, Inc. Compositions, methods and kits for diagnosis of lung cancer
AU2012358246B2 (en) 2011-12-21 2018-01-25 Integrated Diagnostics, Inc. Methods for diagnosis of lung cancer
CN104115150B (zh) * 2012-02-17 2018-05-04 皇家飞利浦有限公司 急性肺损伤(ali)/急性呼吸窘迫整合征(ards)评估和监测
WO2014074682A1 (en) 2012-11-07 2014-05-15 Somalogic, Inc. Chronic obstructive pulmonary disease (copd) biomarkers and uses thereof
KR102310799B1 (ko) * 2013-11-07 2021-10-12 미디얼 리서치 리미티드 폐암 위험 평가 방법 및 시스템
KR102087373B1 (ko) * 2015-09-11 2020-03-10 주식회사 압타머사이언스 비소세포성 폐암 진단용 단백질 바이오마커 패널 및 이를 이용한 비소세포성 폐암 진단 방법
FR3050269B1 (fr) * 2016-04-15 2018-05-11 Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris (Espci) Procede de selection et de recuperation de produits et systeme associe
CN105823665A (zh) * 2016-05-13 2016-08-03 北京九州柏林生物科技有限公司 生物组织样本制备套液
KR20190026769A (ko) 2016-06-21 2019-03-13 더 위스타 인스티튜트 오브 아나토미 앤드 바이올로지 유전자 발현 프로파일을 사용하여 폐암을 진단하기 위한 조성물 및 방법
JP6280997B1 (ja) * 2016-10-31 2018-02-14 株式会社Preferred Networks 疾患の罹患判定装置、疾患の罹患判定方法、疾患の特徴抽出装置及び疾患の特徴抽出方法
WO2018187496A2 (en) 2017-04-04 2018-10-11 Lung Cancer Proteomics, Llc Plasma based protein profiling for early stage lung cancer prognosis
EP3676393A4 (en) 2017-09-01 2021-10-13 Venn Biosciences Corporation IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR DIAGNOSIS AND MONITORING OF TREATMENT
CN111630602A (zh) * 2017-11-22 2020-09-04 磨石肿瘤生物技术公司 减少新抗原的接合表位呈递
JP2021506308A (ja) 2017-12-19 2021-02-22 ザ・ウイスター・インステイテユート・オブ・アナトミー・アンド・バイオロジー 遺伝子発現プロファイルを使用して肺癌を診断するための組成物および方法
CN112638845B (zh) * 2018-06-22 2024-07-30 私募蛋白质体运营有限公司 改进的蛋白质组学多重测定
US20220397575A1 (en) * 2019-06-21 2022-12-15 National University Of Singapore Methods for determining the likelihood of lung cancer
CN110579611B (zh) * 2019-09-18 2023-01-31 郑州大学 一种用于肺癌早期筛查和诊断的联合检测血清标志物、试剂盒及检测方法
CN111047609B (zh) * 2020-03-13 2020-07-24 北京深睿博联科技有限责任公司 肺炎病灶分割方法和装置
CN113960235B (zh) * 2020-10-10 2023-03-14 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 生物标志物在制备肺癌检测试剂中的用途和方法
CN112557514B (zh) * 2020-12-22 2021-09-21 中国海洋大学 手持式海底沉积物样品剖面声学全自动测量装置
WO2025137139A1 (en) * 2023-12-18 2025-06-26 Caris Mpi, Inc. Dynamic tissue typing

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596503B1 (en) * 2000-08-18 2003-07-22 East Carolina University Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
IL157872A0 (en) * 2001-03-12 2004-03-28 Monogen Inc A panel for detecting a generic disease state containing a plurality of probes and using cell-based diagnosis
EP1463928A2 (en) * 2001-04-18 2004-10-06 Protein Design Labs Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
US8014952B2 (en) * 2002-12-18 2011-09-06 Queen Elizabeth Hospital Serum biomarkers in lung cancer
CN1225477C (zh) * 2003-03-28 2005-11-02 上海市疾病预防控制中心 肺癌早期血清特异蛋白及其应用
CN1455257A (zh) * 2003-05-23 2003-11-12 北京师范大学 一种利用表面修饰蛋白芯片进行肺癌诊断方法
ES2360073T3 (es) * 2004-03-23 2011-05-31 Oncotherapy Science, Inc. Método para diagnosticar cáncer de pulmón de células no pequeñas.
JP2005304497A (ja) * 2004-03-25 2005-11-04 Joji Inasawa 特定の癌関連遺伝子を用いる癌の検出方法及び癌の抑制方法
US7456027B2 (en) * 2004-04-15 2008-11-25 University Of Florida Research Foundation, Inc. Proteolytic biomarkers for traumatic injury to the nervous system
WO2005103281A2 (en) * 2004-04-26 2005-11-03 Children's Medical Center Corporation Platelet biomarkers for the detection of disease
AU2005278136A1 (en) * 2004-08-02 2006-03-02 Children's Medical Center Corporation Platelet biomarkers for cancer
CN1873417A (zh) * 2005-06-02 2006-12-06 中国医学科学院肿瘤医院肿瘤研究所 一种用于诊断肺癌的蛋白质芯片
JP5160447B2 (ja) * 2005-12-22 2013-03-13 アボット・ラボラトリーズ 肺がんへの傾向についてのスクリーニングのための方法およびマーカー組合せ
US7908091B2 (en) * 2006-03-17 2011-03-15 Prometheus Laboratories Inc. Methods of predicting and monitoring tyrosine kinase inhibitor therapy
US20080195327A1 (en) * 2006-10-17 2008-08-14 Synergenz Bioscience Limited Methods of Analysis of Polymorphisms and Uses Thereof
US20110119776A1 (en) * 2007-02-05 2011-05-19 Wong Kwok-Kin Methods of diagnosing and prognosing lung cancer
KR100846354B1 (ko) * 2007-03-21 2008-07-15 (주) 프로탄바이오 혈청 당단백질부터 분리한 폐암 진단용 마커
US20100184773A1 (en) * 2007-05-18 2010-07-22 Heinz-Josef Lenz Germline Polymorphisms in the Angiogenic Pathway Predict Tumor Recurrence in Cancer Therapy
WO2009036123A1 (en) * 2007-09-11 2009-03-19 Cancer Prevention And Cure, Ltd. Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues
WO2010003772A1 (en) * 2008-06-16 2010-01-14 Siemens Medical Solutions Diagnostics Gmbh Method for predicting adverse response to erythropoietin in breast cancer treatment
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
CN102906275A (zh) * 2010-02-10 2013-01-30 加利福尼亚大学董事会 肺癌检测的唾液生物标记

Also Published As

Publication number Publication date
GB201106053D0 (en) 2011-05-25
KR101658347B1 (ko) 2016-09-21
AU2015249113B2 (en) 2017-09-07
CA3011730A1 (en) 2010-03-18
CA3152591C (en) 2023-08-29
WO2010030697A1 (en) 2010-03-18
MX2011002322A (es) 2011-05-10
HK1204062A1 (zh) 2015-11-06
CA2734535C (en) 2018-08-28
CA3011730C (en) 2022-05-17
HRP20160127T1 (hr) 2016-03-11
SI2340506T1 (sl) 2016-02-29
CN104198709A (zh) 2014-12-10
EP2340506B1 (en) 2015-11-11
CN102209968A (zh) 2011-10-05
AU2015249113A1 (en) 2015-11-12
DK2340506T3 (en) 2016-02-08
JP2012502281A (ja) 2012-01-26
AU2009291811A1 (en) 2010-03-18
KR20110063753A (ko) 2011-06-14
CA2734535A1 (en) 2010-03-18
HK1153834A1 (en) 2012-04-05
JP5701212B2 (ja) 2015-04-15
EP2340506A4 (en) 2012-02-15
GB2478441A (en) 2011-09-07
AU2009291811B2 (en) 2015-10-29
EP2340506A1 (en) 2011-07-06
CN102209968B (zh) 2016-05-04
GB2478441B (en) 2013-03-27
CA3152591A1 (en) 2010-03-18

Similar Documents

Publication Publication Date Title
ES2559758T3 (es) Biomarcadores de cáncer de pulmón y usos de los mismos
Wu et al. Aptamer-based microfluidics for isolation, release and analysis of circulating tumor cells
Li et al. Emerging nanotechnologies for liquid biopsy: the detection of circulating tumor cells and extracellular vesicles
Mehan et al. Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics
Fang et al. Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach
Hamula et al. Selection and analytical applications of aptamers
Cho et al. Quantitative selection and parallel characterization of aptamers
Dickey et al. Oligonucleotide aptamers: A next-generation technology for the capture and detection of circulating tumor cells
Zhu et al. DNA nanotechnology in tumor liquid biopsy: Enrichment and determination of circulating biomarkers
Gedi et al. Sensitive on-chip detection of cancer antigen 125 using a DNA aptamer/carbon nanotube network platform
I Hernandez et al. Aptamers overview: selection, features and applications
JP2002508191A5 (cg-RX-API-DMAC7.html)
WO2005052548A2 (en) Method for adjusting the quantification range of individual analytes in a multiplexed assay
Shalaby et al. Targeting cerebrospinal fluid for discovery of brain cancer biomarkers
US8841095B2 (en) Detection of nucleic acids and proteins
Wang et al. Immunomagnetic antibody plus aptamer pseudo-DNA nanocatenane followed by rolling circle amplication for highly-sensitive CTC detection
ES2986757T3 (es) Métodos de detección basados en ácidos nucleicos
Zhu et al. Selection and characterization of an ssDNA aptamer against thyroglobulin
Zhang et al. Recent advances in aptamer-based liquid biopsy
KR101200553B1 (ko) 베스핀에 특이적으로 결합하는 앱타머, 그 앱타머의 제조방법 그리고 그 앱타머의 용도
Zeng et al. Highly sensitive and specific graphene oxide-based FRET aptasensor for quantitative detection of human soluble growth stimulating gene protein 2
Uyar et al. Early cancer detection based on exosome biosensors in biological samples
Azuaje-Hualde et al. Paper based microfluidic platform for single-step detection of mesenchymal stromal cells secreted VEGF
Yoshida et al. Quantitative and sensitive protein detection strategies based on aptamers
He et al. Dual-encoded affinity microbead signature combinatorial profiling for acute myocardial infarction high-sensitivity diagnosis